GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » EPS (Diluted)

Q2M Biotech AG (HAM:QBI) EPS (Diluted) : € (TTM As of . 20)


View and export this data going back to 2011. Start your Free Trial

What is Q2M Biotech AG EPS (Diluted)?

Q2M Biotech AG's Earnings per Share (Diluted) for the three months ended in . 20 was €0.00.

Q2M Biotech AG's EPS (Basic) for the three months ended in . 20 was €0.00.

Q2M Biotech AG's EPS without NRI for the three months ended in . 20 was €0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Q2M Biotech AG EPS (Diluted) Historical Data

The historical data trend for Q2M Biotech AG's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q2M Biotech AG EPS (Diluted) Chart

Q2M Biotech AG Annual Data
Trend
EPS (Diluted)

Q2M Biotech AG Quarterly Data
EPS (Diluted)

Competitive Comparison of Q2M Biotech AG's EPS (Diluted)

For the Biotechnology subindustry, Q2M Biotech AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q2M Biotech AG's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q2M Biotech AG's PE Ratio distribution charts can be found below:

* The bar in red indicates where Q2M Biotech AG's PE Ratio falls into.



Q2M Biotech AG EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Q2M Biotech AG's Diluted EPS for the fiscal year that ended in . 20 is calculated as

Diluted EPS (A: . 20 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

Q2M Biotech AG's Diluted EPS for the quarter that ended in . 20 is calculated as



Q2M Biotech AG  (HAM:QBI) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Q2M Biotech AG EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Q2M Biotech AG's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Q2M Biotech AG (HAM:QBI) Business Description

Traded in Other Exchanges
N/A
Address
Haeschenstrasse 17-19, Bremen, DEU
Website
Q2M Biotech AG is a biotechnology company that examines and explains genetic information. The Company is also involved in the creation, development and sale of products, systems and solutions in the biotechnology field.

Q2M Biotech AG (HAM:QBI) Headlines

No Headlines